Perihematomal Edema and Clinical Outcome After Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.

Abstract

Perihematomal edema (PHE) has been proposed as a radiological marker of secondary injury and therapeutic target in intracerebral hemorrhage (ICH). We conducted a systematic review and meta-analysis to assess the prognostic impact of PHE on functional outcome and mortality in patients with ICH. We searched major databases through December 2020 using predefined keywords. Any study using logistic regression to examine the association between PHE or its growth and functional outcome was included. We examined the overall pooled effect and conducted secondary analyses to explore the impact of individual PHE measures on various outcomes separately. Study quality was assessed by three independent raters using the Newcastle-Ottawa Scale. Odds ratios (per 1-unit increase in PHE) and their confidence intervals (CIs) were log transformed and entered into a DerSimonian-Laird random-effects meta-analysis to obtain pooled estimates of the effect. Twenty studies (n = 6633 patients) were included in the analysis. The pooled effect size for overall outcome was 1.05 (95% CI 1.02-1.08; p < 0.00). For the following secondary analyses, the effect size was weak: mortality (1.01; 95%CI 0.90-1.14), functional outcome (1.04; 95%CI 1.02-1.07), both 90-day (1.06; 95%CI 1.02-1.11), and in-hospital assessments (1.04; 95%CI 1.00-1.08). The effect sizes for PHE volume and PHE growth were 1.04 (95%CI 1.01-1.07) and 1.14 (95%CI 1.04-1.25), respectively. Heterogeneity across studies was substantial except for PHE growth. This meta-analysis demonstrates that PHE volume within the first 72h after ictus has a weak effect on functional outcome and mortality after ICH, whereas PHE growth might have a slightly larger impact during this timeframe. Definitive conclusions are limited by the large variability of PHE measures, heterogeneity, and different evaluation time points between studies.